Symptomatic Carotid Artery Thrombosis in a Patient Recently Recovered From a COVID-19 Infection
Ilkin Bakirli1,2, Jan Tomka1,2, Marian Pis1,2
1Vascular Surgery, National Institute of Cardiovascular Diseases, Bratislava, SVK.
Insights
COVID-19 infection can cause arterial clots, including carotid thrombosis, even after recovery. This case highlights the need for prophylactic anticoagulation during and after COVID-19 illness.
Area of Science:
- Neurology
- Vascular Medicine
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic with known vascular complications.
- While venous thrombotic events are common, arterial complications, particularly carotid thrombosis, are less understood.
- Limited data exists on the association between COVID-19 and arterial thrombosis, especially in the carotid arteries.
Observation:
- A 66-year-old male with hypertension presented with stroke symptoms (dysarthria, left-sided weakness).
- Initial COVID-19 swab was negative, but CT angiography revealed thrombosis in the brachiocephalic trunk, right subclavian, and right common carotid arteries.
- Lung imaging showed ground-glass opacities typical of COVID-19, and antibody testing confirmed a prior infection.
Findings:
- The patient underwent successful carotid thrombectomy.
- COVID-19 infection is implicated as a significant factor in carotid artery thrombosis due to inflammation, hypercoagulability, and hyperviscosity.
- COVID-19 is identified as an independent risk factor for arterial thrombus formation, irrespective of disease severity.
Implications:
- This case underscores the potential for COVID-19 to cause arterial thrombotic events, including stroke.
- Prophylactic anticoagulation is recommended not only during acute COVID-19 illness but also in the early post-infection period.
- Further research is needed to fully elucidate the mechanisms and long-term risks of COVID-19-associated arterial thrombosis.
Abstract:
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), was initially discovered in December 2019 in China and rapidly spread all over the world to become a pandemic. The most common symptoms of a disease are fever, cough, generalized body ache, weakness, dyspnoea, nausea, vomiting, and diarrhea. Among vascular complications of COVID-19, the venous thrombotic complications, like pulmonary embolism and lower limb deep veins thrombosis, are not uncommon. But data about arterial thrombotic complications of COVID-19, especially carotid thrombosis, are still limited. We are describing a case of stroke due to thrombosis of the right carotid arteries, in a patient who had recovered from asymptomatic COVID-19. A 66-year-old male with arterial hypertension presented to the emergency department with a history of repeated collapse, dysarthria, weakness in the left extremities, and a drop in the left angle of his mouth (National Institutes of Health Stroke Scale [NIHSS]-4). The patient was swabbed for COVID-19 which was negative. A computed tomography angiography (CTA) was obtained which showed thrombosis in the branching point of the brachiocephalic trunk (BCT) continuing into the right subclavian artery (SA) and also into the right common carotid artery (CCA), with a subtotal occlusion of the right CCA, extending into the internal carotid artery (ICA) as well. From the apical lung tissue caught during the CT scan, bilateral, irregular widespread ground-glass opacifications, as well as consolidations and small reticular changes were seen in the lungs, which is typical for COVID-19 infection. A quantitative antibody test for COVID-19 infection was performed with the results showing a strong positivity for IgG antibodies, indicating previous COVID-19 infection. The patient was indicated for a standard carotid thrombectomy, which was performed without complications. It seems that one of the important factors that led to the formation of the thrombus in the carotid arteries was COVID-19 infection-induced inflammation in the atherosclerotic carotid vessels and generalized hypercoagulability as well as hyperviscosity. COVID-19 infection is an independent and important risk factor for the formation of an arterial thrombus during the acute illness and in the early post-COVID-19 period also, regardless of the severity of its course. Prophylactic anticoagulation is needed not only at the time of acute illness but also at the early post-COVID-19 time.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests


